» Articles » PMID: 20937709

A Low Fluence Q-switched Nd:YAG Laser Modifies the 3D Structure of Melanocyte and Ultrastructure of Melanosome by Subcellular-selective Photothermolysis

Overview
Specialty Radiology
Date 2010 Oct 13
PMID 20937709
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Laser treatment using low fluence for melasma was previously introduced to overcome postinflammatory hypermelanosis after Q-switched laser therapy. However, research on the mechanism of this treatment is very limited. In this study, a collimated low fluence 1064 nm Q-switched Nd:YAG laser with a pulse width of <7 ns was applied using top-hat beam mode. The aim of this study was to investigate the mode of action of this laser treatment through electron microscopy. The effectiveness of this treatment was confirmed by clinical photos, melasma area and severity index and spectrophotometer. To understand the mode of action, the three-dimensional structure of melanocytes in the epidermis was analyzed using serial images acquired by a 3VIEW surface block face scanning electron microscope. In the epidermis, after laser treatment, fewer dendrites in the melanocytes were observed compared with pretreatment. In addition, ultrastructural changes in the melanosome were studied using transmission electron microscopy, which showed that laser treatment caused selective photothermolysis on Stage IV melanosome. Therefore, this treatment should be regarded as an effective method for treating melasma through subcellular-selective photothermolysis.

Citing Articles

Successful treatment of challenging Becker's Nevus with continuous low-fluence Q-switched Nd: YAG 1064 nm laser and long-pulsed Nd: YAG 1064 nm laser.

Chang R, Zhou L, Cen Q, Yu W, Han Y, Huang L Lasers Med Sci. 2024; 39(1):262.

PMID: 39438308 DOI: 10.1007/s10103-024-04193-x.


Efficacy of 532-nm Nd: YAG Fractional Picosecond Laser with 9 mm High Coverage Handpiece Micro Lens Array in the Treatment of Facial Partial Unilateral Lentiginosis: A Case Report.

Lueangarun S, Tempark T J Lasers Med Sci. 2024; 15:e24.

PMID: 39188929 PMC: 11345796. DOI: 10.34172/jlms.2024.24.


Global research trends on melasma: a bibliometric and visualized study from 2014 to 2023.

Wang L, Pang Y, Li W, He Q, Zhang X, Liu E Front Pharmacol. 2024; 15:1421499.

PMID: 39119611 PMC: 11306164. DOI: 10.3389/fphar.2024.1421499.


Update on Melasma Treatments.

Jo J, Chae S, Ryu H Ann Dermatol. 2024; 36(3):125-134.

PMID: 38816973 PMC: 11148313. DOI: 10.5021/ad.23.133.


Research Advances in the Treatment of Riehl's Melanosis.

Xu L, Huang Q, Wu T, Mu Y Clin Cosmet Investig Dermatol. 2023; 16:1181-1189.

PMID: 37168093 PMC: 10166104. DOI: 10.2147/CCID.S403090.